U.S. flag

An official website of the United States government

NM_002161.6(IARS1):c.2229+5G>A AND Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 2, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003226048.2

Allele description [Variation Report for NM_002161.6(IARS1):c.2229+5G>A]

NM_002161.6(IARS1):c.2229+5G>A

Gene:
IARS1:isoleucyl-tRNA synthetase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q22.31
Genomic location:
Preferred name:
NM_002161.6(IARS1):c.2229+5G>A
Other names:
NM_001378586.1:c.2229+5G>A
HGVS:
  • NC_000009.12:g.92253357C>T
  • NG_051498.1:g.45400G>A
  • NM_001374299.1:c.2229+5G>A
  • NM_001374300.1:c.2229+5G>A
  • NM_001374301.1:c.2145+5G>A
  • NM_001378569.1:c.2292+5G>A
  • NM_001378571.1:c.2250+5G>A
  • NM_001378572.1:c.2229+5G>A
  • NM_001378573.1:c.2229+5G>A
  • NM_001378574.1:c.2229+5G>A
  • NM_001378575.1:c.2229+5G>A
  • NM_001378576.1:c.2229+5G>A
  • NM_001378577.1:c.2229+5G>A
  • NM_001378578.1:c.2229+5G>A
  • NM_001378579.1:c.2229+5G>A
  • NM_001378580.1:c.2229+5G>A
  • NM_001378582.1:c.2134-1472G>A
  • NM_001378583.1:c.2106+5G>A
  • NM_001378584.1:c.2229+5G>A
  • NM_001378585.1:c.2229+5G>A
  • NM_001378586.1:c.2229+5G>A
  • NM_002161.6:c.2229+5G>AMANE SELECT
  • NM_013417.4:c.2229+5G>A
  • NC_000009.11:g.95015639C>T
Molecular consequence:
  • NM_001374299.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001374300.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001374301.1:c.2145+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378569.1:c.2292+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378571.1:c.2250+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378572.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378573.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378574.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378575.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378576.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378577.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378578.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378579.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378580.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378582.1:c.2134-1472G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378583.1:c.2106+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378584.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378585.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378586.1:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_002161.6:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_013417.4:c.2229+5G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy (GRIDHH)
Synonyms:
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY
Identifiers:
MONDO: MONDO:0014911; MedGen: C4310720; OMIM: 617093

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003922140Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 2, 2023)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV003922140.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

The heterozygous c.2229+5G>A variant in IARS was identified by our study, in the compound heterozygous state along with another variant of uncertain significance (dbSNP ID: rs149536604), in two siblings with microcephaly, seizures, structural brain anomalies, and intellectual disability. These individuals also carried another variant of uncertain significance (dbSNP ID: rs149536604), however the phase of these variants are unknown at this time. The c.2229+5G>A variant in IARS has not been previously reported in individuals with growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy. This variant was absent from large population studies. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the c.2229+5G>A variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3 (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024